Global Imatinib Mesylate Tablets Market Growth (Status and Outlook) 2022-2028

Home/Global Imatinib Mesylate Tablets Market Growth (Status and Outlook) 2022-2028

Global Imatinib Mesylate Tablets Market Growth (Status and Outlook) 2022-2028

Pharma & Healthcare, Drug Delivery, Treatments, Pharmaceutical Manufacturing

Publication ID:

ARS0821050

Publication Date:

August 14, 2021

Pages:

Publisher:

Arsta

Region:

Global

$3,660.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

As the global economy recovers in 2021 and the supply of the industrial chain improves, the Imatinib Mesylate Tablets market will undergo major changes. According to the latest research, the market size of the Imatinib Mesylate Tablets industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Imatinib Mesylate Tablets industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Imatinib Mesylate Tablets market during the next few years. The global Imatinib Mesylate Tablets market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Mesylate Tablets market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

100 mg
400 mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital
Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Teva Pharmaceuticals
Hikma Pharmaceuticals
Apotex Inc
Sun Pharmaceutical Industries
Lupin Limited
Natco Pharma
Getwell Oncology

Table of Contents

Table of Content

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imatinib Mesylate Tablets Market Size 2017-2028
2.1.2 Imatinib Mesylate Tablets Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Imatinib Mesylate Tablets Segment by Type
2.2.1 100 mg
2.2.2 400 mg
2.3 Imatinib Mesylate Tablets Market Size by Type
2.3.1 Imatinib Mesylate Tablets Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
2.4 Imatinib Mesylate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.5 Imatinib Mesylate Tablets Market Size by Application
2.5.1 Imatinib Mesylate Tablets Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)

3 Imatinib Mesylate Tablets Market Size by Player
3.1 Imatinib Mesylate Tablets Market Size Market Share by Players
3.1.1 Global Imatinib Mesylate Tablets Revenue by Players (2020-2022)
3.1.2 Global Imatinib Mesylate Tablets Revenue Market Share by Players (2020-2022)
3.2 Global Imatinib Mesylate Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Imatinib Mesylate Tablets by Regions
4.1 Imatinib Mesylate Tablets Market Size by Regions (2017-2022)
4.2 Americas Imatinib Mesylate Tablets Market Size Growth (2017-2022)
4.3 APAC Imatinib Mesylate Tablets Market Size Growth (2017-2022)
4.4 Europe Imatinib Mesylate Tablets Market Size Growth (2017-2022)
4.5 Middle East & Africa Imatinib Mesylate Tablets Market Size Growth (2017-2022)

5 Americas
5.1 Americas Imatinib Mesylate Tablets Market Size by Country (2017-2022)
5.2 Americas Imatinib Mesylate Tablets Market Size by Type (2017-2022)
5.3 Americas Imatinib Mesylate Tablets Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Imatinib Mesylate Tablets Market Size by Region (2017-2022)
6.2 APAC Imatinib Mesylate Tablets Market Size by Type (2017-2022)
6.3 APAC Imatinib Mesylate Tablets Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Imatinib Mesylate Tablets by Country (2017-2022)
7.2 Europe Imatinib Mesylate Tablets Market Size by Type (2017-2022)
7.3 Europe Imatinib Mesylate Tablets Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Imatinib Mesylate Tablets by Region (2017-2022)
8.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2017-2022)
8.3 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Imatinib Mesylate Tablets Market Forecast
10.1 Global Imatinib Mesylate Tablets Forecast by Regions (2023-2028)
10.1.1 Global Imatinib Mesylate Tablets Forecast by Regions (2023-2028)
10.1.2 Americas Imatinib Mesylate Tablets Forecast
10.1.3 APAC Imatinib Mesylate Tablets Forecast
10.1.4 Europe Imatinib Mesylate Tablets Forecast
10.1.5 Middle East & Africa Imatinib Mesylate Tablets Forecast
10.2 Americas Imatinib Mesylate Tablets Forecast by Country (2023-2028)
10.2.1 United States Imatinib Mesylate Tablets Market Forecast
10.2.2 Canada Imatinib Mesylate Tablets Market Forecast
10.2.3 Mexico Imatinib Mesylate Tablets Market Forecast
10.2.4 Brazil Imatinib Mesylate Tablets Market Forecast
10.3 APAC Imatinib Mesylate Tablets Forecast by Region (2023-2028)
10.3.1 China Imatinib Mesylate Tablets Market Forecast
10.3.2 Japan Imatinib Mesylate Tablets Market Forecast
10.3.3 Korea Imatinib Mesylate Tablets Market Forecast
10.3.4 Southeast Asia Imatinib Mesylate Tablets Market Forecast
10.3.5 India Imatinib Mesylate Tablets Market Forecast
10.3.6 Australia Imatinib Mesylate Tablets Market Forecast
10.4 Europe Imatinib Mesylate Tablets Forecast by Country (2023-2028)
10.4.1 Germany Imatinib Mesylate Tablets Market Forecast
10.4.2 France Imatinib Mesylate Tablets Market Forecast
10.4.3 UK Imatinib Mesylate Tablets Market Forecast
10.4.4 Italy Imatinib Mesylate Tablets Market Forecast
10.4.5 Russia Imatinib Mesylate Tablets Market Forecast
10.5 Middle East & Africa Imatinib Mesylate Tablets Forecast by Region (2023-2028)
10.5.1 Egypt Imatinib Mesylate Tablets Market Forecast
10.5.2 South Africa Imatinib Mesylate Tablets Market Forecast
10.5.3 Israel Imatinib Mesylate Tablets Market Forecast
10.5.4 Turkey Imatinib Mesylate Tablets Market Forecast
10.5.5 GCC Countries Imatinib Mesylate Tablets Market Forecast
10.6 Global Imatinib Mesylate Tablets Forecast by Type (2023-2028)
10.7 Global Imatinib Mesylate Tablets Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Information
11.1.2 Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered
11.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Pharmaceuticals Main Business Overview
11.1.5 Teva Pharmaceuticals Latest Developments
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Information
11.2.2 Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered
11.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Hikma Pharmaceuticals Main Business Overview
11.2.5 Hikma Pharmaceuticals Latest Developments
11.3 Apotex Inc
11.3.1 Apotex Inc Company Information
11.3.2 Apotex Inc Imatinib Mesylate Tablets Product Offered
11.3.3 Apotex Inc Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Apotex Inc Main Business Overview
11.3.5 Apotex Inc Latest Developments
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Information
11.4.2 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered
11.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sun Pharmaceutical Industries Main Business Overview
11.4.5 Sun Pharmaceutical Industries Latest Developments
11.5 Lupin Limited
11.5.1 Lupin Limited Company Information
11.5.2 Lupin Limited Imatinib Mesylate Tablets Product Offered
11.5.3 Lupin Limited Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Lupin Limited Main Business Overview
11.5.5 Lupin Limited Latest Developments
11.6 Natco Pharma
11.6.1 Natco Pharma Company Information
11.6.2 Natco Pharma Imatinib Mesylate Tablets Product Offered
11.6.3 Natco Pharma Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Natco Pharma Main Business Overview
11.6.5 Natco Pharma Latest Developments
11.7 Getwell Oncology
11.7.1 Getwell Oncology Company Information
11.7.2 Getwell Oncology Imatinib Mesylate Tablets Product Offered
11.7.3 Getwell Oncology Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Getwell Oncology Main Business Overview
11.7.5 Getwell Oncology Latest Developments

12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Imatinib Mesylate Tablets Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 100 mg
Table 3. Major Players of 400 mg
Table 4. Imatinib Mesylate Tablets Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Imatinib Mesylate Tablets Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
Table 7. Imatinib Mesylate Tablets Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Imatinib Mesylate Tablets Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)
Table 10. Global Imatinib Mesylate Tablets Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Imatinib Mesylate Tablets Revenue Market Share by Player (2020-2022)
Table 12. Imatinib Mesylate Tablets Key Players Head office and Products Offered
Table 13. Imatinib Mesylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Imatinib Mesylate Tablets Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Imatinib Mesylate Tablets Market Size Market Share by Regions (2017-2022)
Table 18. Americas Imatinib Mesylate Tablets Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Imatinib Mesylate Tablets Market Size Market Share by Country (2017-2022)
Table 20. Americas Imatinib Mesylate Tablets Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
Table 22. Americas Imatinib Mesylate Tablets Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)
Table 24. APAC Imatinib Mesylate Tablets Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Imatinib Mesylate Tablets Market Size Market Share by Region (2017-2022)
Table 26. APAC Imatinib Mesylate Tablets Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
Table 28. APAC Imatinib Mesylate Tablets Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)
Table 30. Europe Imatinib Mesylate Tablets Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Imatinib Mesylate Tablets Market Size Market Share by Country (2017-2022)
Table 32. Europe Imatinib Mesylate Tablets Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
Table 34. Europe Imatinib Mesylate Tablets Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Imatinib Mesylate Tablets Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Imatinib Mesylate Tablets
Table 43. Key Market Challenges & Risks of Imatinib Mesylate Tablets
Table 44. Key Industry Trends of Imatinib Mesylate Tablets
Table 45. Global Imatinib Mesylate Tablets Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Imatinib Mesylate Tablets Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Imatinib Mesylate Tablets Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Application (2023-2028)
Table 51. Teva Pharmaceuticals Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 52. Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered
Table 53. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Teva Pharmaceuticals Main Business
Table 55. Teva Pharmaceuticals Latest Developments
Table 56. Hikma Pharmaceuticals Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 57. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered
Table 58. Hikma Pharmaceuticals Main Business
Table 59. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Hikma Pharmaceuticals Latest Developments
Table 61. Apotex Inc Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 62. Apotex Inc Imatinib Mesylate Tablets Product Offered
Table 63. Apotex Inc Main Business
Table 64. Apotex Inc Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Apotex Inc Latest Developments
Table 66. Sun Pharmaceutical Industries Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 67. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered
Table 68. Sun Pharmaceutical Industries Main Business
Table 69. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sun Pharmaceutical Industries Latest Developments
Table 71. Lupin Limited Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 72. Lupin Limited Imatinib Mesylate Tablets Product Offered
Table 73. Lupin Limited Main Business
Table 74. Lupin Limited Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Lupin Limited Latest Developments
Table 76. Natco Pharma Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 77. Natco Pharma Imatinib Mesylate Tablets Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Natco Pharma Latest Developments
Table 81. Getwell Oncology Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 82. Getwell Oncology Imatinib Mesylate Tablets Product Offered
Table 83. Getwell Oncology Main Business
Table 84. Getwell Oncology Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Getwell Oncology Latest Developments
List of Figures
Figure 1. Imatinib Mesylate Tablets Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Imatinib Mesylate Tablets Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Imatinib Mesylate Tablets Market Size Market Share by Type in 2021
Figure 7. Imatinib Mesylate Tablets in Hospital
Figure 8. Global Imatinib Mesylate Tablets Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Imatinib Mesylate Tablets in Clinics
Figure 10. Global Imatinib Mesylate Tablets Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Global Imatinib Mesylate Tablets Market Size Market Share by Application in 2021
Figure 12. Global Imatinib Mesylate Tablets Revenue Market Share by Player in 2021
Figure 13. Global Imatinib Mesylate Tablets Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Imatinib Mesylate Tablets Market Size 2017-2022 ($ Millions)
Figure 15. APAC Imatinib Mesylate Tablets Market Size 2017-2022 ($ Millions)
Figure 16. Europe Imatinib Mesylate Tablets Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Imatinib Mesylate Tablets Market Size 2017-2022 ($ Millions)
Figure 18. Americas Imatinib Mesylate Tablets Value Market Share by Country in 2021
Figure 19. Americas Imatinib Mesylate Tablets Consumption Market Share by Type in 2021
Figure 20. Americas Imatinib Mesylate Tablets Market Size Market Share by Application in 2021
Figure 21. United States Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Imatinib Mesylate Tablets Market Size Market Share by Region in 2021
Figure 26. APAC Imatinib Mesylate Tablets Market Size Market Share by Application in 2021
Figure 27. China Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Imatinib Mesylate Tablets Market Size Market Share by Country in 2021
Figure 34. Europe Imatinib Mesylate Tablets Market Size Market Share by Type in 2021
Figure 35. Europe Imatinib Mesylate Tablets Market Size Market Share by Application in 2021
Figure 36. Germany Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Application in 2021
Figure 44. Egypt Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Imatinib Mesylate Tablets Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 50. APAC Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 51. Europe Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 53. United States Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 54. Canada Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 57. China Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 58. Japan Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 59. Korea Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 61. India Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 62. Australia Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 63. Germany Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 64. France Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 65. UK Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 66. Italy Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 67. Russia Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 68. Spain Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 71. Israel Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Imatinib Mesylate Tablets Market Size 2023-2028 ($ Millions)

Companies Covered

Teva Pharmaceuticals
Hikma Pharmaceuticals
Apotex Inc
Sun Pharmaceutical Industries
Lupin Limited
Natco Pharma
Getwell Oncology

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".